Precision Biosciences (DTIL) Other financing activities (2018 - 2026)

Precision Biosciences (DTIL) has 7 years of Other financing activities data on file, last reported at $662000.0 in Q1 2026.

• Other financing activities for Q1 2026 came in at $662000.0, down 35.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $662000.0 (down 35.79% YoY), and the FY2025 annual result was $1.0 million, up 13.92% from the prior year.
• Other financing activities fell to $662000.0 in Q1 2026 per DTIL's latest filing, from $1.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $1.0 million in Q1 2025 and troughed at $662000.0 in Q1 2026.
• A 3-year average of $866000.0 and a median of $905000.0 in 2024 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2025 and 2026: Other financing activities climbed 13.92% in 2025, then tumbled 35.79% in 2026.
• A 3-year view of Other financing activities shows it stood at $905000.0 in 2024, then rose by 13.92% to $1.0 million in 2025, then tumbled by 35.79% to $662000.0 in 2026.
• Business Quant data shows DTIL's Other financing activities at $662000.0 in Q1 2026, $1.0 million in Q1 2025, and $905000.0 in Q1 2024.